Clinical-scale expansion of mesenchymal stromal cells: a large banking experience

BACKGROUND: Mesenchymal stromal cells (MSC) are largely investigated in clinical trials aiming to control inappropriate immune reactions (GVHD, Crohn’s disease, solid organ transplantation). As the percentage of MSC precursors in bone marrow is very low, these must be expanded in vitro to obtain the...

Descripción completa

Detalles Bibliográficos
Autores principales: Lechanteur, Chantal, Briquet, Alexandra, Giet, Olivier, Delloye, Olivier, Baudoux, Etienne, Beguin, Yves
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4875672/
https://www.ncbi.nlm.nih.gov/pubmed/27207011
http://dx.doi.org/10.1186/s12967-016-0892-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4875672/
https://www.ncbi.nlm.nih.gov/pubmed/27207011
http://dx.doi.org/10.1186/s12967-016-0892-y

Ejemplares similares